Theralase Technologies Market Cap

Theralase Technologies has a market cap or net worth of CAD 89.60 million as of April 28, 2026. Its market cap has increased by 100.06% in one year.

Market Cap

89.60M

Enterprise Value

89.84M

Revenue

1.00M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.33

Market Cap Chart

Since April 2, 1996, Theralase Technologies's market cap has increased from 8.33M to 89.60M, an increase of 975.96%. That is a compound annual growth rate of 8.22%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	107.52M	145.99%
Dec 31, 2025	43.71M	-33.43%
Dec 31, 2024	65.66M	64.23%
Dec 28, 2023	39.98M	-42.29%
Dec 30, 2022	69.28M	-9.56%
Dec 31, 2021	76.60M	97.37%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Cannabix Technologies	93.36M
Perimeter Medical Imaging AI	43.54M
Conavi Medical	41.91M
Cheelcare	35.20M
Profound Medical	347.02M
Aurora Spine	21.30M
Ventripoint Diagnostics	19.70M
MedX Health	18.04M

Market Cap Rankings